Same-day transradial outpatient stenting with a 6-hr course of glycoprotein IIb/IIIa receptor blockade: A feasibility study

Catheterization and Cardiovascular Interventions

Volumn 56, Issue 1, 2002, Pages 10-13

  Gilchrist, Ian C ^a   Nickolaus, Michelle J ^a   Momplaisir, Thierry ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

Angioplasty; Percutaneous coronary; Stents; Transluminal

Indexed keywords

ANTITHROMBOCYTIC AGENT; CREATINE KINASE; EPTIFIBATIDE; FIBRINOGEN RECEPTOR ANTAGONIST;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; CORONARY STENT; CREATINE KINASE BLOOD LEVEL; DEMOGRAPHY; DIABETES MELLITUS; FEASIBILITY STUDY; FEMALE; HUMAN; HYPERLIPIDEMIA; IATROGENIC DISEASE; LENGTH OF STAY; MALE; OUTCOMES RESEARCH; OUTPATIENT; OUTPATIENT CARE; PATIENT EDUCATION; RECEPTOR BLOCKING; UNSTABLE ANGINA PECTORIS;

ADULT; AGED; AMBULATORY SURGICAL PROCEDURES; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ASPIRIN; BLOOD VESSEL PROSTHESIS IMPLANTATION; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; CREATINE KINASE; ELECTROCARDIOGRAPHY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; STENTS; STROKE VOLUME; TICLOPIDINE; TIME FACTORS; TREATMENT OUTCOME;

EID: 0036242805     PISSN: 15221946     EISSN: None     Source Type: Journal    
DOI: 10.1002/ccd.10093     Document Type: Article

References (15)

1. Incidence, predictors and management of acute coronary occlusion after coronary angioplasty
2. Systematic use of transradial approach or suture of the femoral artery after angioplasty: Attempt at achieving zero access site complications
3. Effect of transradial access on quality of life and cost of cardiac catheterization: A randomized comparison
4. Vascular complications and clinical outcome after coronary angioplasty with platelet IIb/IIIa receptor blockade: Comparison of transradial vs transfemoral arterial access
5. Fewer bleeding complications with comparable efficacy with transradial approach in coronary artery stenting: An analysis of the ESPRIT Trial
6. Outpatient coronary stenting: Femoral approach with vascular sealing
7. Outpatient coronary stent implantation
8. A randomized comparison of percutaneous transluminal coronary angioplasty by the radial, brachial and femoral approaches: The Access study
9. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty
10. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: Implications for inhibition of the internal pool of GP IIb/IIIa receptors
11. Platelet glycoprotein IIb/IIIa antagonists: What are the relevant issues concerning their pharmacology and clinical use?
12. Pharmacodynamic profile of short-term abciximab treatment demonstrates prolonged platelet inhibition with gradual recovery from GP IIb/IIIa receptor blockade
13. Timing of and risk factors for myocardial ischemic events after percutaneous coronary intervention (IMPACT-II)
14. Temporal spectrum of ischemic complications with percutaneous coronary intervention: The ESPRIT experience
15. Effect of glycoprotein IIb/IIIa receptor inhibition on in-lab adverse events and subsequent CK-MB elevation during percutanous coronary intervention in ESPRIT